A股異動 | 航錦科技(000818.SZ)高開6.75% 公司主要產品燒鹼(各濃度)價格全面上調
格隆匯9月23日丨航錦科技(000818.SZ)高開6.75%,報33.7元,總市值230億元。航錦科技公佈,公司受市場行情因素影響,公司主要產品燒鹼(各濃度)價格全面上調,在現有燒鹼銷售價格基礎上,國內客户折百液鹼銷售價格近一週累計上調1320元/噸,累計漲幅約51%。公司將密切跟蹤燒鹼價格的走勢及供需情況變化,及時做好燒鹼產品的調價工作。公司主營產品銷售價格全面上調有助於進一步提升公司的持續盈利能力,有利於提高公司的市場地位和影響力。受公司月度定價、季度定價影響,本次調價對第三季度業績並無影響,預計對第四季度經營業績產生積極影響。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.